Valuation : Bionime Corporation

Market Cap 4.56B 145M 124M 117M 107M 200M 13.68B 200M 1.39B 536M 7B 543M 531M 22.31B P/E 2024
-31x
P/E 2025 -22.2x
Enterprise Value 7.14B 226M 195M 183M 167M 312M 21.39B 313M 2.17B 838M 10.95B 849M 831M 34.89B EV / Sales 2024
3.48x
EV / Sales 2025 3.58x
Free-Float
47.17%
Yield 2024 *
-
Yield 2025 -
1 day+0.68%
1 week+2.08%
Current month+2.43%
1 month+9.26%
3 months+7.27%
6 months-4.38%
Current year-0.84%
1 week 56.5
Extreme 56.5
59.1
1 month 54.9
Extreme 54.9
59.1
Current year 49.75
Extreme 49.75
72.9
1 year 49.75
Extreme 49.75
73.9
3 years 43.14
Extreme 43.14154
81.92
5 years 43.14
Extreme 43.14154
88.92
10 years 40.73
Extreme 40.73216
88.92
Manager TitleAgeSince
Chief Executive Officer - 2010-07-08
Director of Finance/CFO - 2017-11-05
Chief Tech/Sci/R&D Officer - 2018-11-06
Director TitleAgeSince
Chairman - 2003-04-13
Director/Board Member - 2007-10-16
Director/Board Member - 2013-06-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.68%+2.08%-17.12%-15.06% 143M
+0.23%-0.06%+168.44%+369.49% 21.66B
-2.29%-3.59%-38.67%-20.92% 10.16B
-0.90%+1.80%+348.78%+20.09% 8.16B
-0.99%-2.18%-28.06% - 7.08B
-0.01%+0.20%+84.42%+51.31% 6.59B
-1.11%-2.36%-21.62%-13.93% 6.03B
-1.75%-3.37%-10.08%-20.68% 4.33B
+2.96%+2.56%+80.17%+92.05% 4.22B
-1.43%-1.69%-19.83%-30.01% 2.81B
Average -0.46%-0.13%+54.64%+48.04% 7.12B
Weighted average by Cap. -0.54%-0.29%+92.24%+131.37%

Financials

2024 2025
Net sales 1.93B 61.29M 52.71M 49.57M 45.25M 84.63M 5.8B 84.91M 588M 227M 2.97B 230M 225M 9.45B 1.84B 58.27M 50.11M 47.13M 43.03M 80.47M 5.51B 80.73M 559M 216M 2.82B 219M 214M 8.99B
Net income -127M -4.03M -3.47M -3.26M -2.98M -5.57M -381M -5.59M -38.67M -14.95M -195M -15.14M -14.81M -622M -180M -5.71M -4.91M -4.62M -4.22M -7.89M -540M -7.92M -54.8M -21.18M -277M -21.46M -20.99M -881M
Net Debt 2.78B 88.24M 75.88M 71.37M 65.15M 122M 8.34B 122M 846M 327M 4.27B 331M 324M 13.61B 2.57B 81.57M 70.15M 65.98M 60.23M 113M 7.71B 113M 782M 302M 3.95B 306M 300M 12.58B
Logo Bionime Corporation
Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.
Employees
-
Date Price Change Volume
26-09-06 NT$59.00 +0.68% 158,485
26-09-04 NT$58.60 +1.56% 209,634
26-09-03 NT$57.70 +0.52% 62,011
26-09-02 NT$57.40 -0.17% 53,200
26-09-01 NT$57.50 -0.17% 67,923

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4737 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!